InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,742.01
(
-0.06%
)
US TECH 100
19,480.40
(
-0.50%
)
Dow Jones
42,372.42
(
0.47%
)
Brent Oil
71.59
(
0.90%
)
Bitcoin
65,934.00
(
1.16%
)
Post# of 1291
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

papaul

Send PM Follow Ignore
Followers 11
Posts 1418
Boards Moderated 0
Alias Born 07/07/2009

papaul

Re: papaul post# 173

Thursday, 11/10/2011 11:00:26 AM

Thursday, November 10, 2011 11:00:26 AM

Post# of 1291
Three reports today are not helping us.

JMP Securities lowered its stock-investment rating on Savient Pharmaceuticals Inc. (SVNT, $2.86, -$0.12, -4.03%) to market underperform from market perform, citing limited growth potential for the specialty biopharmaceutical company's Krystexxa gout treatment drug.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up